Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [843]
News [2102]
Articles [21]
Editorials [1]
Conferences [129]
elearning [2]
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
30 Jun 2020
CTC count as a prognostic marker for androgen deprivation plus orteronel or...
Dr Amir Goldkorn - Keck School of Medicine of USC, Los Angeles, USA
CTC count as a prognostic marker for androgen deprivation plus orteronel or bicalutamide in mCSPC ( Dr Amir Goldkorn - Keck School of Medicine of USC, Los Angeles, USA )
12 Jun 2020
PARP inhibitors in prostate cancer: Choices of tests and how to test?
Dr Kim Chi and Dr Alexander Wyatt
PARP inhibitors in prostate cancer: Choices of tests and how to test? ( Dr Kim Chi and Dr Alexander Wyatt )
11 Jun 2020
ASCO 2020: Breast cancer roundup
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
ASCO 2020: Breast cancer roundup ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
11 Jun 2020
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple...
Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy
FORTE trial: Minimal residual disease evaluation in newly diagnosed multiple myeloma ( Dr Stefania Oliva - GIMEMA, European Myeloma Network, Italy )
11 Jun 2020
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as...
Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta...
CheckMate 227 three-year update: Nivolumab plus ipilimumab versus chemo as first-line treatment for advanced NSCLC ( Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, USA )
2 Jun 2020
The paediatric precision oncology study INFORM: Clinical outcome and benefit...
Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg...
The paediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups ( Dr Cornelis van Tilburg - Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany )
30 May 2020
Using cancer research strategies to develop an anti-coronavirus vaccine
Dr Bernard Fox - Providence Cancer Institute, Portland, USA
Using cancer research strategies to develop an anti-coronavirus vaccine ( Dr Bernard Fox - Providence Cancer Institute, Portland, USA )
20 Apr 2020
Managing multiple myeloma during the COVID-19 outbreak
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Managing multiple myeloma during the COVID-19 outbreak ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
17 Apr 2020
Treating TRK fusion cancer: Selecting between available agents
Prof Marc Peeters and Dr David Hong
Treating TRK fusion cancer: Selecting between available agents ( Prof Marc Peeters and Dr David Hong )
3 Apr 2020
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019
Prof Marc Peeters and Prof Jesus Garcia-Foncillas
Updates in treating NTRK fusion cancer: Highlights from ESMO 2019 ( Prof Marc Peeters and Prof Jesus Garcia-Foncillas )
9 Mar 2020
PRIAS: Active surveillance for men with low risk prostate cancer
Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The...
PRIAS: Active surveillance for men with low risk prostate cancer ( Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The Netherlands )
24 Feb 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation